India · English
Centre to require pharmas to distinguish biologics from synthetics
The government plans to require pharmaceutical companies to differentiate between biologics and synthetic drugs to clarify regulations for products like semaglutide.
Read the full report at Livemint →
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.